Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
101.69
+0.77 (0.76%)
At close: Apr 28, 2026, 4:00 PM EDT
101.69
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Encompass Health Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Encompass Health stock have an average target of 143.29, with a low estimate of 125 and a high estimate of 160. The average target predicts an increase of 40.91% from the current stock price of 101.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 6, 2026.
Analyst Ratings
The average analyst rating for Encompass Health stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $150 → $153 | Buy | Maintains | $150 → $153 | +50.46% | Feb 6, 2026 |
| Barclays | Barclays | Buy Maintains $141 → $150 | Buy | Maintains | $141 → $150 | +47.51% | Oct 30, 2025 |
| UBS | UBS | Strong Buy Maintains $140 → $150 | Strong Buy | Maintains | $140 → $150 | +47.51% | Oct 2, 2025 |
| Keybanc | Keybanc | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +37.67% | Sep 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $145 → $160 | Strong Buy | Maintains | $145 → $160 | +57.34% | Sep 10, 2025 |
Financial Forecast
Revenue This Year
6.49B
from 5.94B
Increased by 9.33%
Revenue Next Year
7.02B
from 6.49B
Increased by 8.14%
EPS This Year
6.02
from 5.54
Increased by 8.62%
EPS Next Year
6.54
from 6.02
Increased by 8.65%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.8B | 7.4B | ||
| Avg | 6.5B | 7.0B | ||
| Low | 6.3B | 6.8B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 14.2% | 14.0% | ||
| Avg | 9.3% | 8.1% | ||
| Low | 5.9% | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 6.32 | 7.11 | ||
| Avg | 6.02 | 6.54 | ||
| Low | 5.73 | 5.86 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 14.1% | 18.1% | ||
| Avg | 8.6% | 8.6% | ||
| Low | 3.5% | -2.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.